Deciding whether you should participate in a study or clinical trial is an important personal decision. Your decision is best made with a full understanding of the process of drug development and your specific role. While the choice is ultimately yours, we also highly recommend that you first discuss it with your physician, as well as members of your family and friends. Learn more about our clinical trials and how you can get involved.
The Crohn's & Colitis Foundation of America’s (CCFA) also maintains a comprehensive database of studies, clinical trials, and other research into Crohn's Disease and Ulcerative Colitis. You can use the search tool below to access listings for current and upcoming opportunities to participate in this research. Search by keyword, or specify which disease you have been diagnosed with, as well as your location, to help narrow your search.
340013816|*|45.0244667|*|-93.4796711|*|15700 37th Ave N|*|Plymouth|*|55446|*|MN|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MN-1.html|*||*|,MN340013720|*|41.7900327|*|-87.5964047|*|5751 S Woodlawn Ave|*|Chicago|*|60637|*|IL|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-IL-1.html|*||*|,IL417470341|*||*||*||*||*||*||*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study.html|*||*|,CA,FL,IL,IA,KY,MA,MN,MO,NH,NY,NC,OH,PA,RI,TN,TX,VT,VA,WI340014101|*|29.7099106|*|-95.4014139|*|1709 Dryden Rd|*|Houston|*|77030|*|TX|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-TX.html|*||*|,TX340013767|*|42.3319167|*|-71.0988025|*||*|Boston|*|02120|*|MA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MA-1.html|*||*|,MA340013786|*|42.3618645|*|-71.0654433|*|165 Cambridge St|*|Boston|*|02114|*|MA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MA-2.html|*||*|,MA340013801|*|42.336226|*|-71.072918|*|85 E Concord St|*|Boston|*|02118|*|MA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MA-3.html|*||*|,MA340013903|*|40.7700703|*|-73.9580246|*||*||*|10021|*|NY|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NY-1.html|*||*|,NY340013830|*|44.0221363|*|-92.4666658|*|200 1st St SW|*|Rochester|*|55902|*|MN|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MN-2.html|*||*|,MN340013847|*|38.6212468|*|-90.2526163|*||*|St Louis|*|63110|*|MO|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-MO.html|*||*|,MO340013875|*|35.930263|*|-79.0545828|*|880 Martin Luther King Jr Blvd|*|Chapel Hill|*|27514|*|NC|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NC-2.html|*||*|,NC340013735|*|40.1146839|*|-88.207964|*|221 N Broadway Ave|*|Urbana|*|61801|*|IL|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-IL-2.html|*||*|,IL340014142|*|43.0772547|*|-89.430773|*||*|Madison|*|53792|*|WI|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-WI-1.html|*||*|,WI340013861|*|36.0906339|*|-80.2715805|*|Medical Center Blvd|*|Winston-Salem|*|27103|*|NC|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NC-1.html|*||*|,NC340014031|*|41.5059114|*|-81.6071514|*|11100 Euclid Ave|*|Cleveland|*|44106|*|OH|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-OH.html|*||*|,OH340014049|*|39.9583587|*|-75.1953934|*||*|Philadelphia|*|19104|*|PA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-PA.html|*||*|,PA340013988|*|40.8426138|*|-73.9431882|*|722 W 168th St|*|New York|*|10032|*|NY|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NY-2.html|*||*|,NY340014011|*|40.7813372|*|-73.9600272|*|12 E 86th St|*|New York|*|10028|*|NY|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NY-3.html|*||*|,NY340013703|*|41.659363|*|-91.5487099|*||*|Iowa City|*|52242|*|IA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-IA.html|*||*|,IA340014116|*|37.5433009|*|-77.4293184|*||*|Richmond|*|23298|*|VA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-VA.html|*||*|,VA340014081|*|36.1390165|*|-86.7969244|*||*|Nashville|*|37212|*|TN|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-TN.html|*||*|,TN340014129|*|44.4795901|*|-73.2005961|*|1 S Prospect St|*|Burlington|*|05401|*|VT|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-VT.html|*||*|,VT340014159|*|43.043614|*|-88.020787|*|8701 W Watertown Plank Rd|*|Milwaukee|*|53226|*|WI|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-WI-2.html|*||*|,WI340014066|*|41.8139504|*|-71.4124533|*|90 Plain St|*|Providence|*|02903|*|RI|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-RI.html|*||*|,RI340013674|*|37.784511|*|-122.440412|*|2330 Post St|*|San Francisco|*|94115|*|CA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-CA-2.html|*||*|,CA340013686|*|29.63923|*|-82.34331|*||*|Gainesville|*|32610|*|FL|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-FL.html|*||*|,FL340013888|*|43.64|*|-72.25|*||*|Lebanon|*|03756|*|NH|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-NH.html|*||*|,NH340013660|*|34.073582|*|-118.380947|*|8635 W 3rd St|*|Los Angeles|*|90048|*|CA|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-CA-1.html|*||*|,CA340013751|*|38.0328237|*|-84.5067424|*||*|Lexington|*|40536|*|KY|*|A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease (PIANO)|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/piano-study/piano-pregnancy-study-KY.html|*||*|,KY408818022|*|25.7652875|*|-80.2318935|*|2260 Southwest 8th Street #301|*|Miami|*|33135|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-31.html|*||*|,FL409191281|*|41.722536|*|-71.4757577|*|400 Bald Hill Road|*|Warwick|*|02886|*|RI|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-47.html|*||*|,RI409191294|*|42.3360028|*|-71.1070437|*|75 Francis Street|*|Brookline|*|02446|*|MA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-68.html|*||*|,MA409191302|*|27.9926734|*|-82.4842713|*|5115 North Armenia Avenue|*|Tampa|*|33603|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-48.html|*||*|,FL408813674|*|33.187764|*|-117.29112|*|3923 Waring Road|*|Oceanside|*|92056|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-14.html|*||*|,CA408811914|*|30.303823|*|-97.747891|*|1305 West 34th Street #408|*|Austin|*|78705|*|TX|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-64.html|*||*|,TX408814216|*|38.247803|*|-85.746768|*|401 East Chestnut Street #310|*|Louisville|*|40202|*|KY|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-16.html|*||*|,KY418993066|*|41.5022348|*|-81.6172193|*|9500 Euclid Avenue|*|Cleveland|*|44195|*|OH|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-77.html|*||*|,OH418995630|*|38.815017|*|-94.521029|*|108 Congress|*|Belton|*|64012|*|MO|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-82.html|*||*|,MO418995623|*|32.232429|*|-110.840042|*|7140 East Rosewood Street|*|Tucson|*|85710|*|AZ|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-83.html|*||*|,AZ418995617|*|40.6091459|*|-75.3921246|*|701 Ostrum Street #604|*|Bethlehem|*|18015|*|PA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-74.html|*||*|,PA418997696|*|29.7099106|*|-95.4014139|*|1709 Dryden Road #800|*|Houston|*|77030|*|TX|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-30.html|*||*|,TX358580494|*|38.977058|*|-94.357611|*|3601 NE Ralph Powell Rd|*|Lee's Summit|*|64064|*|MO|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-05.html|*||*|,MO358629889|*|33.9173225|*|-117.998095|*|15627 Imperial Hwy|*|La Mirada|*|90638|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-43.html|*||*|,CA358580705|*|41.262391|*|-96.069646|*|10040 Regency Cir #375|*|Omaha|*|68114|*|NE|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-34.html|*||*|,NE358585631|*|41.7051376|*|-88.1263479|*|319 Weber Rd|*|Bolingbrook|*|60490|*|IL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-41.html|*||*|,IL358629906|*|32.776124|*|-117.05425|*|6719 Alvarado Rd #201|*|San Diego|*|92120|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-51.html|*||*|,CA358629882|*|43.611479|*|-116.263061|*|6565 W Emerald St|*|Boise|*|83704|*|ID|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-49.html|*||*|,ID358580372|*|40.7852363|*|-73.7086352|*|1000 Northern Blvd #160|*|Great Neck|*|11020|*|NY|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-07.html|*||*|,NY358580693|*|41.7504995|*|-87.9155677|*|80 Burr Ridge Pkwy #139|*|Burr Ridge|*|60527|*|IL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-15.html|*||*|,IL358590991|*|25.751114|*|-80.303938|*|6700 SW 21st St|*|Miami|*|33155|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-25.html|*||*|,FL358580499|*|39.803203|*|-75.043464|*|1504 Blackwood Clementon Rd|*|Gloucester Township|*|08012|*|NJ|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-32.html|*||*|,NJ358590974|*|30.411556|*|-97.706421|*|12221 N Mopac Expy|*|Austin|*|78758|*|TX|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-20.html|*||*|,TX409063585|*|35.901785|*|-79.0535174|*|130 Mason Farm Road|*|Chapel Hill|*|27514|*|NC|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-75.html|*||*|,NC358585635|*|26.1593348|*|-81.7909861|*|1064 Goodlette-Frank Rd|*|Naples|*|34102|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-61.html|*||*|,FL409063591|*|25.7649187|*|-80.2583387|*|747 Ponce De Leon Boulevard #700|*|Coral Gables|*|33134|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-71.html|*||*|,FL408807688|*|33.859551|*|-118.150739|*|5750 Downey Avenue #206|*|Lakewood|*|90712|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-57.html|*||*|,CA408814689|*|26.0204691|*|-80.1788494|*|1150 North 35th Avenue #445|*|Hollywood|*|33021|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-17.html|*||*|,FL408810234|*|42.9148404|*|-78.7840443|*|2625 Harlem Road #240|*|Cheektowaga|*|14225|*|NY|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-40.html|*||*|,CA408811316|*|33.7825845|*|-118.1681727|*|1932 East Anaheim Street|*|Long Beach|*|90813|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-62.html|*||*|,CA408815321|*|29.7241|*|-95.387781|*|1200 Binz Street #800|*|Houston|*|77004|*|TX|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-18.html|*||*|,TX408815890|*|41.980974|*|-76.518676|*|1 Guthrie Sq|*|Sayre|*|18840|*|PA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-22.html|*||*|,PA409070762|*|36.1427786|*|-86.8000741|*|1211 21st Avenue South|*|Nashville|*|37212|*|TN|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-54.html|*||*|,TN409070756|*|42.6532407|*|-73.7762779|*|47 New Scotland Avenue|*|Albany|*|12208|*|NY|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-63.html|*||*|,NY358585622|*|40.745337|*|-73.980128|*|215 Lexington Ave|*|New York|*|10016|*|NY|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-27.html|*||*|,NY358580709|*|32.7712366|*|-117.00589|*|5119 Garfield St|*|La Mesa|*|91942|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-36.html|*||*|,CA358585627|*|39.901163|*|-79.7550614|*|25 Highland Park Dr #201|*|Uniontown|*|15401|*|PA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-35.html|*||*|,PA358580560|*|40.88275|*|-74.010206|*|718 Teaneck Rd|*|Teaneck|*|07666|*|NJ|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-59.html|*||*|,NJ358585647|*|29.6545897|*|-82.3888472|*|4343 W Newberry Rd #17|*|Gainesville|*|32607|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-58.html|*||*|,FL358580701|*|36.082769|*|-80.304033|*|210 Charlois Blvd #110|*|Winston-Salem|*|27103|*|NC|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-60.html|*||*|,NC409070749|*|33.805601|*|-118.150657|*|2600 Redondo Avenue #500|*|Long Beach|*|90806|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-52.html|*||*|,CA409070768|*|42.2825887|*|-83.7267076|*|1500 East Medical Center Drive|*|Ann Arbor|*|48109|*|MI|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-66.html|*||*|,MI408818008|*|26.1843359|*|-80.201503|*|4700 North State Road 7 #111|*|Lauderdale Lakes|*|33319|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-46.html|*||*|,FL409070774|*|40.4379259|*|-79.9556424|*||*|Pittsburgh|*|15213|*|PA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-81.html|*|200 Lothrop Street, C-Wing, Mezzanine Level, Pittsburgh, PA 15213-2536|*|,PA358580713|*|40.6032439|*|-79.162341|*|1265 Wayne Ave #301|*|Indiana|*|15701|*|PA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-65.html|*||*|,PA408812516|*|34.747987|*|-92.342463|*|500 South University Avenue #500|*|Little Rock|*|72205|*|AR|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-70.html|*||*|,AR408813062|*|42.349512|*|-71.063308|*|800 Washington Street|*|Boston|*|02111|*|MA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-13.html|*||*|,MA408809015|*|30.3084145|*|-81.6891278|*|Shircliff Way|*|Jacksonville|*|32204|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-9.html|*||*|,FL408816859|*|41.7892591|*|-87.6049321|*|5841 South Maryland Avenue|*|Chicago|*|60637|*|IL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-28.html|*||*|,IL408816441|*|39.558169|*|-119.733425|*|3160 North Truckee Lane|*|Sparks|*|89434|*|NV|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-26.html|*||*|,NV408816865|*|28.3021987|*|-81.4110108|*|710 Oak Commons Boulevard|*|Kissimmee|*|34741|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-29.html|*||*|,FL408805234|*|37.9581919|*|-87.501641|*|1401 Professional Boulevard #100|*|Evansville|*|47714|*|IN|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-12.html|*||*|,IN408818002|*|27.9931425|*|-82.7420454|*|2147 Old Coachman Road|*|Clearwater|*|33763|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-44.html|*||*|,FL408818015|*|37.4985659|*|-77.470892|*|1200 Broad Rock Boulevard|*|Richmond|*|23224|*|VA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-38.html|*||*|,VA409191288|*|41.6609219|*|-91.5479994|*|200 Hawkins Drive|*|Iowa City|*|52242|*|IA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-50.html|*||*|,IA409191308|*|39.9963417|*|-83.0160645|*|395 West 12th Avenue #266|*|Columbus|*|43210|*|OH|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-67.html|*||*|,OH409063569|*|37.5011021|*|-122.2549688|*|1000 Laurel Street|*|San Carlos|*|94070|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-78.html|*||*|,CA409063577|*|42.057571|*|-87.978799|*|1415 South Arlington Heights Road|*|Arlington Heights|*|60005|*|IL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-80.html|*||*|,IL409063597|*|29.044659|*|-81.315087|*|860 Peachwood Drive|*|DeLand|*|32720|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-72.html|*||*|,FL358580546|*|47.432817|*|-120.321996|*|820 N Chelan Ave|*|Wenatchee|*|98801|*|WA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-04.html|*||*|,WA358580126|*|33.8501765|*|-117.9245959|*|1085 N Harbor Blvd|*|Anaheim|*|92801|*|CA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-01.html|*||*|,CA358630778|*|34.746708|*|-92.399032|*|11219 Financial Centre Pkwy #206|*|Little Rock|*|72211|*|AR|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-56.html|*||*|,AR358585639|*|39.1330793|*|-84.5001478|*|2925 Vernon Pl #200|*|Cincinnati|*|45219|*|OH|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-37.html|*||*|,OH358630786|*|45.790477|*|-108.51707|*|1045 N 30th St|*|Billings|*|59101|*|Mt|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-55.html|*||*|,MT358580689|*|41.6825663|*|-81.2993753|*|9485 Mentor Ave|*|Mentor|*|44060|*|OH|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-19.html|*||*|,OH358590982|*|39.9869287|*|-105.1014582|*|1000 W South Boulder Rd #200|*|Lafayette|*|80026|*|CO|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-21.html|*||*|,CO358629878|*|38.868549|*|-77.234423|*|3022 Williams Dr #301|*|Fairfax|*|22031|*|VA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-45.html|*||*|,VA358585643|*|39.054213|*|-95.692334|*|720 SW Lane St|*|Topeka|*|66606|*|KS|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-42.html|*||*|,KS358590987|*|32.250115|*|-110.871304|*|5656 E Grant Rd|*|Tucson|*|85712|*|AZ|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-24.html|*||*|,AZ358580684|*|45.5309059|*|-122.6964387|*|1130 NW 22nd Ave #410|*|Portland|*|97210|*|OR|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-06.html|*||*|,OR358580554|*|39.158509|*|-91.876767|*|714 Medical Park Dr|*|Mexico|*|65265|*|MO|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-08.html|*||*|,MO358629900|*|34.0699775|*|-84.1723229|*|4395 Johns Creek Pkwy|*|Suwanee|*|30024|*|GA|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-53.html|*||*|,GA358580697|*|36.114013|*|-95.9399785|*|3345 S Harvard Ave #301|*|Tulsa|*|74135|*|OK|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-33.html|*||*|,OK358590978|*|42.256717|*|-85.6897854|*|7110 Stadium Dr|*|Kalamazoo|*|49009|*|MI|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-23.html|*||*|,MI358580550|*|42.676265|*|-82.804801|*|30795 23 Mile Rd #206|*|Chesterfield|*|48047|*|MI|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-10.html|*||*|,MI349525782|*|28.598041|*|-81.358368|*|701 W Morse Blvd|*|Winter Park|*|32789|*|FL|*|A Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period in patients with moderately to severely active Crohn’s disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/TRUST-I-03.html|*||*|,FL340012585|*|36.7578013|*|-76.2131474|*||*|Chesapeake|*|23320|*|VA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-VA-2.html|*||*|,VA340011000|*|32.6385134|*|-117.0617553|*||*|Chula Vista|*|91910|*|CA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CA-5.html|*||*|,CA340011082|*|41.4305881|*|-72.9106202|*||*|Hamden|*|06518|*|CT|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CT-1.html|*||*|,CT340010885|*|34.7486563|*|-92.3542193|*||*|Little Rock|*|72205|*|AR|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-AR-3.html|*||*|,AR340011439|*|34.0514898|*|-84.0712997|*||*|Suwanee|*||*|GA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-GA-4.html|*||*|,GA340011253|*|26.0197012|*|-80.1819268|*||*|Hollywood|*|33021|*|FL|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-FL-9.html|*||*|,FL340012570|*|37.3466983|*|-79.2112769|*||*|Lynchburg|*|24502|*|VA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-VA-1.html|*||*|,VA340011055|*|39.6696322|*|-104.9330448|*||*|Denver|*|80222|*|CO|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-CO-1.html|*||*|,CO340011407|*|33.944647|*|-84.3226488|*||*|Atlanta|*|30338|*|GA|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-GA-2.html|*||*|,GA340011124|*|27.8580624|*|-82.7616822|*||*|Seminole|*|33777|*|FL|*|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety of Budesonide Foam Versus Placebo In Subjects With Active Mild to Moderate Ulcerative Proctitis (UP) Or Proctosigmoiditis (UPS)|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/budesonide-foam-ulcerative-proctitis-proctosigmoiditis-study-FL-1.html|*||*|,FL366256391|*|39.158509|*|-91.876767|*|714 Medical Park Dr|*|Mexico|*|65265|*|MO|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840024.html|*||*|,MO366256386|*|29.585773|*|-95.630281|*|4760 Sweetwater Blvd #101|*|Sugar Land|*|77479|*|TX|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840038.html|*||*|,TX366275449|*|40.2161294|*|-75.5409888|*|420 Linfield Trappe Rd|*|Limerick|*|19468|*|PA|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840045.html|*|Building B, Suite 101|*|,PA366275480|*|33.4922225|*|-81.9717253|*|336 Georgia Ave #207|*|North Augusta|*|29841|*|SC|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840073.html|*||*|,GA366275476|*|39.56786|*|-105.000782|*|1001 Southpark Dr|*|Littleton|*|80120|*|CO|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840061.html|*||*|,CO366275472|*|27.987971|*|-82.745793|*|1831 N Belcher Rd|*|Clearwater|*|33765|*|FL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840050.html|*|Suite F-1|*|,FL366275463|*|26.554948|*|-80.148862|*|8188 Jog Rd #204|*|Boynton Beach|*|33472|*|FL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840054.html|*||*|,FL366275485|*|40.7848303|*|-73.7088017|*|1000 Northern Blvd #160|*|Great Neck|*|11020|*|NY|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840051.html|*||*|,NY366275453|*|38.327007|*|-76.553438|*|24035 Three Notch Rd|*|Hollywood|*|20636|*|MD|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840049.html|*||*|,MD366275445|*|39.1330793|*|-84.5001478|*|2925 Vernon Pl #200|*|Cincinnati|*|45219|*|OH|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840046.html|*||*|,OH366207591|*|41.7116183|*|-87.7767876|*|9921 Southwest Hwy|*|Oak Lawn|*|60453|*|IL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840005.html|*||*|,IL366256378|*|43.0661001|*|-88.0479651|*|2645 N Mayfair Rd #200|*|Milwaukee|*|53226|*|WI|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840064.html|*||*|,WI366275468|*|26.1593348|*|-81.7909861|*|1064 Goodlette-Frank Rd|*|Naples|*|34102|*|FL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840044.html|*||*|,FL366256373|*|39.7397594|*|-105.0745956|*|7000 W Colfax Ave|*|Lakewood|*|80214|*|CO|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840030.html|*||*|,CO366209351|*|34.2739372|*|-118.4680057|*|11165 Sepulveda Blvd|*|Mission Hills|*|91345|*|CA|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840059.html|*||*|,CA366275490|*|28.637353|*|-81.364591|*|260 Lookout Pl #201|*|Maitland|*|32751|*|FL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840041.html|*||*|,FL366256366|*|29.650816|*|-95.170356|*|4001 Preston Ave #125|*|Pasadena|*|77505|*|TX|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840019.html|*||*|,TX366275459|*|28.598041|*|-81.358368|*|701 W Morse Blvd|*|Winter Park|*|32789|*|FL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840048.html|*||*|,MI366209360|*|34.761265|*|-77.377998|*|4 Office Park Dr|*|Jacksonville|*|28546|*|NC|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840018.html|*||*|,NC366256397|*|34.0590552|*|-118.4120816|*|2080 Century Park E|*|Los Angeles|*|90067|*|CA|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840031.html|*||*|,CA366209356|*|42.860259|*|-85.716263|*|2093 Health Dr SW #201|*|Wyoming|*|49519|*|MI|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840011.html|*||*|,MI366207763|*|25.972231|*|-80.2990416|*|11460 Interchange Cir N|*|Miramar|*|33025|*|FL|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840008.html|*||*|,FL366256382|*|30.408083|*|-88.762772|*|3890 Bienville Blvd|*|Ocean Springs|*|39564|*|MS|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840060.html|*||*|,MS364282359|*|33.4638847|*|-112.3513066|*|13555 W McDowell Rd #209|*|Goodyear|*|85395|*|AZ|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840065.html|*||*|,AZ366209347|*|39.9799488|*|-83.0634768|*|1335 Dublin Rd|*|Columbus|*|43215|*|OH|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840006.html|*|106A|*|,OH366207767|*|32.7073457|*|-117.0854656|*|292 Euclid Ave #115|*|San Diego|*|92102|*|CA|*|A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC).|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/FUSCIA-840074.html|*||*|,CA346179660|*||*||*||*||*||*||*|A Randomized, Double-Blind. Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Budesonide MMX 9 mg Extended-release Tablets as Add-on Therapy in Patients with Active Mild or Moderate Ulcerative Colitis not Adequately Controlled on a Background Oral 5-ASA Regimen (also referred to as "The Contribute Study")|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/oral-budesonide-mmx9-1.html|*||*|,AL,CA,CO,CT,FL,GA,IL,IN,IA,KS,LA,MD,MI,MN,MS,MO,NH,NJ,NY,NC,OH,PA,TX,UT,VA,WA,WI387684807|*||*||*||*||*||*||*|A Study to Assess Effectiveness of Communication to Patients and Caregivers/Parents of Children with Moderately to Severely Active Ulcerative Colitis |*|,ulcerative-colitis|*|,adult-18,pediatric-under-18|*|,female,male|*||*|,national-study|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/communication-study.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY352497612|*|41.980421|*|-76.521449|*|1 Guthrie Sq|*|Sayre|*|18840|*|PA|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-135.html|*||*|,PA352497618|*|41.7912669|*|-87.6055351|*|5758 S Maryland Ave|*|Chicago|*|60637|*|IL|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-283.html|*||*|,IL352497199|*|41.372948|*|-81.832177|*|18660 Bagley Rd #102b|*|Middleburg Heights|*|44130|*|OH|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-339.html|*||*|,OH352496712|*|41.376728|*|-72.904673|*|2200 Whitney Ave #370|*|Hamden|*|06518|*|CT|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-141.html|*||*|,CT352515652|*|27.8721341|*|-82.7525479|*|8250 Bryan Dairy Rd #200|*|Seminole|*|33777|*|FL|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-412.html|*||*|,FL352515641|*|41.826943|*|-73.1005944|*|245 Alvord Park Rd|*|Torrington|*|06790|*|CT|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-389.html|*||*|,CT352497639|*|32.8328365|*|-83.6295729|*|610 3rd St #204|*|Macon|*|31201|*|GA|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-388.html|*||*|,GA352497205|*|40.7852363|*|-73.7086352|*|1000 Northern Blvd #160|*|Great Neck|*|11020|*|NY|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-132.html|*||*|,NY352494199|*|42.057571|*|-87.978799|*|1415 S Arlington Heights Rd|*|Arlington Heights|*|60005|*|IL|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-119.html|*||*|,IL352494979|*|30.4153528|*|-91.0865044|*|9103 Jefferson Hwy|*|Baton Rouge|*|70809|*|LA|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-124.html|*||*|,LA352515955|*|43.4724304|*|-111.9885836|*|2770 Cortez Ave|*|Idaho Falls|*|83404|*|ID|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-413.html|*||*|,ID352515948|*|36.146241|*|-95.96674|*|1145 S Utica Ave #807|*|Tulsa|*|74104|*|OK|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-390.html|*||*|,OK352515647|*|40.0410255|*|-75.5006396|*|325 Central Ave|*|Malvern|*|19355|*|PA|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-392.html|*||*|,PA352495529|*|33.909086|*|-84.350774|*|5671 Peachtree Dunwoody Rd NE #512|*|Atlanta|*|30342|*|GA|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-128.html|*||*|,GA352497632|*|26.1593348|*|-81.7909861|*|1064 Goodlette-Frank Rd|*|Naples|*|34102|*|FL|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-360.html|*||*|,FL352515636|*|43.0779247|*|-89.433678|*|1685 Highland Ave|*|Madison|*|53705|*|WI|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-403.html|*||*|,WI352497645|*|36.1776166|*|-86.6083939|*|5653 Frist Blvd #530|*|Nashville|*|37076|*|TN|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-387.html|*||*|,TN352497625|*|33.7626661|*|-84.3717|*|285 Boulevard NE #240|*|Atlanta|*|30312|*|GA|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-341.html|*||*|,GA352497193|*|34.105094|*|-80.951944|*|11 Gateway Corners Park|*|Columbia|*|29203|*|SC|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-384.html|*||*|,SC350676165|*|43.6728744|*|-72.2722639|*|Medical Center Dr|*|Lebanon|*|03766|*|NH|*|A Study to Assess the Association of Clinical Outcome with Serum Drug Concentration Levels and Anti-Drug Antibody in Moderately to Severely Active Crohn’s Disease Patients Treated With Adalimumab|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/Adalimumab-P-006.html|*||*|,NH340014914|*|35.113164|*|-89.807704|*|1310 Wolf Park Dr|*|Germantown|*|38138|*|TN|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TN-1.html|*||*|,TN340014770|*|40.7425742|*|-73.9788203|*|232 E 30th St|*|New York|*|10016|*|NY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NY-2.html|*||*|,NY340015030|*|47.6264794|*|-122.2051487|*||*|Bellevue|*|98004|*|WA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-WA.html|*||*|,WA340014340|*|32.8328365|*|-83.6295729|*|610 3rd St|*|Macon|*|31201|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-2.html|*||*|,GA340014373|*|33.909086|*|-84.350774|*|5671 Peachtree Dunwoody Rd NE|*|Atlanta|*|30342|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-4.html|*||*|,GA340014403|*|37.640618|*|-98.7212339|*|420 Country Club Rd|*|Pratt|*|67124|*|KS|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-KS.html|*||*|,KS340014439|*|39.022126|*|-84.560647|*|425 Centre View Blvd|*|Crestview Hills|*|41017|*|KY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-KY-2.html|*||*|,KY340014174|*|34.7549716|*|-92.3408659|*|409 N University Ave|*|Little Rock|*|72205|*|AR|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-AR.html|*||*|,AR340014226|*|32.726688|*|-117.16071|*|2001 4th Ave|*|San Diego|*|92101|*|CA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-CA-2.html|*||*|,CA340014309|*|30.250598|*|-81.585323|*|4800 Belfort Rd|*|Jacksonville|*|32256|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-4.html|*||*|,FL340014356|*|33.790891|*|-84.283258|*|2675 N Decatur Rd|*|Decatur|*|30033|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-3.html|*||*|,GA340014454|*|30.4153528|*|-91.0865044|*|9103 Jefferson Hwy|*|Baton Rouge|*|70809|*|LA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-LA.html|*||*|,LA340014190|*|32.2327704|*|-110.8397441|*|7140 E Rosewood St|*|Tucson|*|85710|*|AZ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-AZ.html|*||*|,AZ340014787|*|39.6874296|*|-83.9556877|*|W Main St|*|Xenia|*|45385|*|OH|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OH-1.html|*||*|,OH340015000|*|36.741709|*|-76.245979|*|112 Gainsborough Square|*|Chesapeake|*|23320|*|VA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-VA-1.html|*||*|,VA340014241|*|37.9769836|*|-121.7104289|*|312 Ridge Crest Ct|*|Oakley|*|94561|*|CA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-CO.html|*||*|,CO340014326|*|34.0699775|*|-84.1723229|*|4395 Johns Creek Pkwy|*|Suwanee|*|30024|*|GA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-GA-1.html|*||*|,GA340014421|*|38.0329491|*|-84.5258045|*|1401 Harrodsburg Rd|*|Lexington|*|40504|*|KY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-KY-1.html|*||*|,KY340014563|*|42.682375|*|-82.769859|*|23 Mile Rd|*|Chesterfield|*|48047|*|MI|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MI-2.html|*||*|,MI340014689|*|39.8828|*|-74.9247|*|406 Lippincott Dr|*||*|08053|*|NJ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NJ-1.html|*||*|,NJ340014490|*|49.8469725|*|-99.9429021|*|339 Princess Ave|*|Brandon|*|R7A 3G8|*|MB|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MB.html|*||*|340014808|*|39.1330793|*|-84.5001478|*|2925 Vernon Pl|*|Cincinnati|*|45219|*|OH|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OH-2.html|*||*|,OH340014845|*|36.146241|*|-95.96674|*|1145 S Utica Ave|*|Tulsa|*|74104|*|OK|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OK-2.html|*||*|,OK340014972|*|30.303823|*|-97.747891|*|1305 W 34th St|*|Austin|*|78705|*|TX|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TX-2.html|*||*|,TX340014986|*|32.936633|*|-97.09702|*|2020 W State Highway 114|*|Grapevine|*|76051|*|TX|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TX-3.html|*||*|,TX340014899|*|32.979071|*|-80.063205|*|2671 Elms Plantation Blvd|*|Charleston|*|29406|*|SC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-SC.html|*||*|,SC340014262|*|26.1593348|*|-81.7909861|*|1064 Goodlette-Frank Rd|*|Naples|*|34102|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-1.html|*||*|,FL340014213|*|33.8101772|*|-118.3520389|*||*|Torrance|*|90505|*|CA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-CA-1.html|*||*|,CA340014277|*|28.598041|*|-81.358368|*|701 W Morse Blvd|*|Winter Park|*|32789|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-2.html|*||*|,FL340014293|*|29.65445|*|-82.38871|*|4343 W Newberry Rd|*|Gainesville|*|32607|*|FL|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-FL-3.html|*||*|,FL340014390|*|41.602158|*|-93.789019|*|1378 NW 124th St|*|Clive|*|50325|*|IA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-IA.html|*||*|,IA340014468|*|42.258897|*|-71.813676|*|26 Queen St|*|Worcester|*|01610|*|MA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MA.html|*||*|,MA340014510|*|38.963947|*|-77.089841|*|5550 Friendship Blvd|*|Chevy Chase|*|20815|*|MD|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MD-1.html|*||*|,MD340014882|*|40.0410255|*|-75.5006396|*|325 Central Ave|*|Malvern|*|19355|*|PA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-PA.html|*||*|,PA340014931|*|36.1286652|*|-86.8452282|*|4230 Harding Rd|*|Nashville|*|37205|*|TN|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TN-2.html|*||*|,TN340014526|*|39.386024|*|-76.606981|*|7402 York Rd|*|Towson|*|21204|*|MD|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MD-2.html|*||*|,MD340014598|*|39.158509|*|-91.876767|*|714 Medical Park Dr|*|Mexico|*|65265|*|MO|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MO-2.html|*||*|,MO340014630|*|30.408083|*|-88.762772|*|3890 Bienville Blvd|*|Ocean Springs|*|39564|*|MS|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MS.html|*||*|,MS340014730|*|40.7967667|*|-74.4815438|*||*|Morristown|*||*|NJ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NJ-3.html|*||*|,NJ340014752|*|40.7850406|*|-73.7085886|*|1000 Northern Blvd|*|Manhasset|*|11020|*|NY|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NY-1.html|*||*|,NY340014825|*|35.229673|*|-97.4410929|*|900 N Porter Ave|*|Norman|*|73071|*|OK|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OK-1.html|*||*|,OK340014864|*|44.0651477|*|-121.2672679|*|1501 NE Medical Center Dr|*|Bend|*|97701|*|OR|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-OR.html|*||*|,OR340014616|*|38.977058|*|-94.357611|*|3601 NE Ralph Powell Rd|*|Lee's Summit|*|64064|*|MO|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MO-3.html|*||*|,MO340014645|*|35.208552|*|-80.821922|*|2015 Randolph Rd|*|Charlotte|*|28207|*|NC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NC-1.html|*||*|,NC340014669|*|35.8162672|*|-78.7071459|*|2601 Lake Dr|*|Raleigh|*|27607|*|NC|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NC-2.html|*||*|,NC340014709|*|39.383257|*|-74.57416|*|3205 Fire Rd|*|Egg Harbor Township|*|08234|*|NJ|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-NJ-2.html|*||*|,NJ340014544|*|42.5882045|*|-83.1693778|*|4550 Investment Dr|*|Troy|*|48098|*|MI|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MI-1.html|*||*|,MI340014576|*|39.0052407|*|-94.5794342|*|6675 Holmes Rd|*|Kansas City|*|64131|*|MO|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-MO-1.html|*||*|,MO340014952|*|32.330224|*|-95.289603|*|1720 S Beckham Ave|*|Tyler|*|75701|*|TX|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-TX-1.html|*||*|,TX340015015|*|36.86571|*|-76.029211|*|1101 First Colonial Rd|*|Virginia Beach|*|23454|*|VA|*|A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease|*|,crohns-disease|*|,adult-18|*|,female,male|*|,moderate,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ustekinumab-crohns-study-VA-2.html|*||*|,VA417453340|*|47.628523|*|-122.329977|*|1100 Fairview Avenue North|*|Seattle|*|98109|*|WA|*|Allogeneic hematopoietic cell transplantation for patients with treatment-refractory Crohn’s Disease: A phase 2 study|*|,crohns-disease|*|,adult-18|*|,female,male|*|,severe|*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/allogeneic-transplant-study.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY340015043|*||*||*||*||*||*||*|Autoimmune Diseases in Pregnancy Study|*|,crohns-disease|*|,adult-18|*|,female|*||*|,other|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/autoimmune-diseases-pregnancy-study.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY427018764|*||*||*||*||*||*||*|Beliefs in Medications and Treatment Complexity as Predictors of Medication Adherence among Adults 18-65 years-old with Inflammatory Bowel Disease|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,other|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/beliefs-adherence.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY342563884|*|35.901785|*|-79.0535174|*||*||*||*||*|CCFA Partners - Patients helping patients|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,ccfa-partners|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ccfa-partners-patients.html|*||*|,NC346515343|*||*||*||*||*||*||*|CCFA Partners - Patients helping patients|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,national-study|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/ccfa-partners-patients-national.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY342343421|*|39.2904539|*|-76.623772|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_md.html|*||*|,MD342343461|*|44.9669985|*|-93.2370211|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mn3.html|*||*|,MN342343248|*|45.0244667|*|-93.4796711|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mn2.html|*||*|,MN342343197|*|40.78977|*|-73.952515|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ny2.html|*||*|,NY342343099|*|43.6728744|*|-72.2722639|*|Medical Center Dr|*|Lebanon|*|03766|*|NH|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nh.html|*||*|,NH342342939|*|33.909086|*|-84.350774|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ga.html|*||*|,GA342343547|*|40.7709485|*|-111.8397483|*|30 N 1900 E|*|Salt Lake City|*|84132|*|UT|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ut.html|*||*|,UT342343483|*|35.9131996|*|-79.0558445|*||*|Chapel Hill|*||*|NC|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nc.html|*||*|,NC342343403|*|38.031627|*|-84.509255|*|800 Rose St|*|Lexington|*|40508|*|KY|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ky.html|*||*|,KY342342971|*|42.336226|*|-71.072918|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma1.html|*||*|,MA342343442|*|42.2842782|*|-83.7345314|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mi.html|*||*|,MD342343624|*|37.5429664|*|-77.43505|*|612 E Marshall St|*|Richmond|*|23219|*|VA|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_va.html|*||*|,VA342343340|*|39.1396644|*|-84.5042008|*|231 Albert Sabin Way|*|Cincinnati|*|45229|*|OH|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_oh3.html|*||*|,OH342343060|*|42.3361712|*|-71.1009382|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma3.html|*||*|,MA342343136|*|41.8412068|*|-71.4154382|*|44 W River St|*|Providence|*|02904|*|RI|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ri2.html|*||*|,RI342343164|*|40.7738568|*|-73.9607231|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ny1.html|*||*|,NY342343181|*|42.3588106|*|-71.1239582|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma4.html|*||*|,MA342343276|*|41.8084946|*|-71.4117197|*|33 Staniford St|*|Providence|*|02905|*|RI|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ri3.html|*||*|,RI342343293|*|41.5059114|*|-81.6071514|*|11100 Euclid Ave|*|Cleveland|*|44106|*|OH|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_oh2.html|*||*|,OH342343641|*|36.0906339|*|-80.2715805|*|Medical Center Blvd|*|Winston-Salem|*|27103|*|NC|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nc2.html|*||*|,NC342343314|*|37.784511|*|-122.440412|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ca2.html|*||*|,CA342343527|*|40.4419009|*|-79.9604392|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_pa2.html|*||*|,PA342343564|*|44.384136|*|-73.199615|*|267 Maeck Farm Rd|*|Shelburne|*|05482|*|VT|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_vt.html|*||*|,VT342342990|*|42.3584308|*|-71.0597732|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ma2.html|*||*|,MA342343022|*|34.073582|*|-118.380947|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ca1.html|*||*|,CA342343042|*|41.843654|*|-71.414823|*|146 W River St|*|Providence|*|02904|*|RI|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ri1.html|*||*|,RI342343150|*|32.8328365|*|-83.6295729|*|610 3rd St|*|Macon|*|31201|*|GA|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ga2.html|*||*|,GA342343600|*|36.1430277|*|-86.8000138|*|1211 21st Ave S|*|Nashville|*|37212|*|TN|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_tn.html|*||*|,TN342343662|*|35.8442108|*|-78.7125935|*|Duraleigh Rd|*|Raleigh|*|27612|*|NC|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_nc3.html|*||*|,NC342343006|*|41.7892569|*|-87.6049376|*|5841 S Maryland Ave|*|Chicago|*|60637|*|IL|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_il.html|*||*|,IL342343081|*|41.50464|*|-81.621627|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_oh1.html|*||*|,OH342343119|*|46.7928158|*|-92.0964445|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_mn.html|*||*|,MN342343211|*|30.263886|*|-81.4428306|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_fl1.html|*||*|,FL342343229|*|33.5857641|*|-111.7935598|*|13400 E Shea Blvd|*|Scottsdale|*|85259|*|AZ|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_az.html|*||*|,AZ342343385|*|41.6569617|*|-91.5478736|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_ia.html|*||*|,IA342343506|*|39.9518965|*|-75.1939518|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_pa1.html|*||*|,PA342343585|*|43.076345|*|-89.4313395|*||*||*||*||*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_wi.html|*||*|,WI342342956|*|29.7099106|*|-95.4014139|*|1709 Dryden Rd|*|Houston|*|77030|*|TX|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_tx.html|*||*|,TX342343359|*|29.6397981|*|-82.3433446|*|1600 SW Archer Rd|*|Gainesville|*|32603|*|FL|*|Clinical Research Alliance Member|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,clinical-research-alliance|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/cra_fl2.html|*||*|,FL422217770|*||*||*||*||*||*||*|Health-Related Quality of Life in Inflammatory Bowel Disease|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,other|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/quality-of-life.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY342345575|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_17.html|*||*|,MO342345593|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_18.html|*||*|,NC342345747|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_27.html|*||*|,NY342345457|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_10.html|*||*|,NC342345505|*|40.4172871|*|-82.907123|*||*||*||*|OH|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_13.html|*||*|,OH342345770|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_28.html|*||*|,CA342345990|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_39.html|*||*|,NY342346023|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_41.html|*||*|,MO342345336|*|38.8951118|*|-77.0363658|*||*|Washington|*||*|DC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_3.html|*||*|,DC342345387|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_6.html|*||*|,NC342345474|*|40.6331249|*|-89.3985283|*||*||*||*|IL|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_11.html|*||*|,IL342345489|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_12.html|*||*|,MO342346227|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_53.html|*||*|342346333|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_59.html|*||*|,NY342346208|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_52.html|*||*|342346251|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_54.html|*||*|342346458|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_65.html|*||*|,WI342346378|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_61.html|*||*|,WI342346650|*|31.9685988|*|-99.9018131|*||*||*||*|TX|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_77.html|*||*|,TX342345833|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_31.html|*||*|,NC342346007|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_40.html|*||*|,MO342346190|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_51.html|*||*|,MA342346440|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_64.html|*||*|,WI342346473|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_66.html|*||*|,MO342346516|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_69.html|*||*|,NY342346266|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_55.html|*||*|342346297|*|39.0457549|*|-76.6412712|*||*||*||*|MD|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_57.html|*||*|,MD342346486|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_67.html|*||*|,NY342346532|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_70.html|*||*|,NY342346632|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_76.html|*||*|,NY342346671|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_78.html|*||*|,NY342346569|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_72.html|*||*|,NY342346685|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_79.html|*||*|,NY342346701|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_80.html|*||*|,NC342345436|*|41.2033216|*|-77.1945247|*||*||*||*|PA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_9.html|*||*|,PA342346717|*|46.818188|*|8.227512|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_81.html|*||*|342346805|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_86.html|*||*|,NY342346746|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_83.html|*||*|,NC342345626|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_20.html|*||*|,NC342345885|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_33.html|*||*|,NY342345956|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_37.html|*||*|,MO342346729|*|46.818188|*|8.227512|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_82.html|*||*|342346790|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_85.html|*||*|,NY342346057|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_43.html|*||*|,MA342346070|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_44.html|*||*|,MA342346115|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_47.html|*||*|,NY342346138|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_48.html|*||*|,MA342346159|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_49.html|*||*|,MA342346284|*|39.0457549|*|-76.6412712|*||*||*||*|MD|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_56.html|*||*|,MD342346313|*|39.0457549|*|-76.6412712|*||*||*||*|MD|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_58.html|*||*|,MD342346353|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_60.html|*||*|,WI342346397|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_62.html|*||*|,WI342345352|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_4.html|*||*|,CA342345370|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_5.html|*||*|,CA342345536|*|31.9685988|*|-99.9018131|*||*||*||*|TX|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_15.html|*||*|,TX342345322|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_2.html|*||*|,CA342346618|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_75.html|*||*|,NY342346087|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_45.html|*||*|,NY342345645|*|40.4172871|*|-82.907123|*||*||*||*|OH|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_21.html|*||*|,OH342345663|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_22.html|*||*|,NC342345678|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_23.html|*||*|,NC342345692|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_24.html|*||*|,MA342346764|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_84.html|*||*|,NY342346823|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_87.html|*||*|,NY342345712|*|32.1574351|*|-82.907123|*||*||*||*|GA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_25.html|*||*|,GA342345908|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_34.html|*||*|,MO342345926|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_35.html|*||*|,MO342346037|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_42.html|*||*|,MA342346500|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_68.html|*||*|,NY342345421|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_8.html|*||*|,NC342345553|*|39.5500507|*|-105.7820674|*||*||*||*|CO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_16.html|*||*|,CO342345797|*|37.9642529|*|-91.8318334|*||*||*||*|MO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_29.html|*||*|,MO342345819|*|39.5500507|*|-105.7820674|*||*||*||*|CO|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_30.html|*||*|,CO342345854|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_32.html|*||*|,NY342345939|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_36.html|*||*|,CA342346101|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_46.html|*||*|,MA342346175|*|56.130366|*|-106.346771|*||*||*||*||*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_50.html|*||*|342346585|*|34.5199402|*|-105.8700901|*||*||*||*|NM|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_73.html|*||*|,NM342345401|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_7.html|*||*|,NY342345727|*|35.7595731|*|-79.0192997|*||*||*||*|NC|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_26.html|*||*|,NC342345304|*|36.778261|*|-119.4179324|*||*||*||*|CA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_1.html|*||*|,CA342345521|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_14.html|*||*|,NY342345610|*|40.6331249|*|-89.3985283|*||*||*||*|IL|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_19.html|*||*|,IL342345976|*|42.4072107|*|-71.3824374|*||*||*||*|MA|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_38.html|*||*|,MA342346416|*|43.7844397|*|-88.7878678|*||*||*||*|WI|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_63.html|*||*|,WI342346550|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_71.html|*||*|,NY342346603|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|Microbiome Consutium|*|,crohns-disease,ulcerative-colitis|*||*||*||*|,human-gut-microbiome-initiative|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/micro_74.html|*||*|,NY422222105|*||*||*||*||*||*||*|Pediatric Parenting Stress among Parents of Children with Inflammatory Bowel Disease: A Comparative Study of Parental Gender & Other Chronic Pediatric Illnesses|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,other|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pediatric-parenting-stress.html|*||*|,AL,AK,AZ,AR,CA,CO,CT,DE,DC,FL,GA,HI,ID,IL,IN,IA,KS,KY,LA,ME,MD,MA,MI,MN,MS,MO,MT,NE,NV,NH,NJ,NM,NY,NC,ND,OH,OK,OR,PA,RI,SC,SD,TN,TX,UT,VT,VA,WA,WV,WI,WY342343786|*|40.7143528|*|-74.0059731|*||*|New York|*||*|NY|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_134.html|*||*|,NY342344459|*|40.4659407|*|-79.9535709|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_121.html|*||*|,PA342344573|*|42.909397|*|-78.875503|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_127.html|*||*|,NY342344510|*|32.8089195|*|-96.8360682|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_124.html|*||*|,TX342344249|*|39.911802|*|-82.799209|*|3554 Creek Meadows Dr|*|Pickerington|*|43147|*|OH|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_109.html|*||*|,OH342344305|*|35.9131996|*|-79.0558445|*||*|Chapel Hill|*||*|NC|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_112.html|*||*|,NC342343706|*|41.9253231|*|-87.6468578|*|2300 N Childrens Plaza|*|Chicago|*|60614|*|IL|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_131.html|*||*|,IL342343838|*|40.7654867|*|-73.9543068|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_135.html|*||*|,NY342343869|*|40.2859239|*|-76.6502468|*||*|Hershey|*||*|PA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_136.html|*||*|,PA342343681|*|40.295635|*|-73.985181|*|300 2nd Ave|*|Long Branch|*|07740|*|NJ|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_130.html|*||*|,NJ342344206|*|40.7527106|*|-73.7074713|*|269-1 76th Ave|*|Queens|*|11040|*|NY|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_107.html|*||*|,NY342344262|*|42.3361712|*|-71.1009382|*|300 Longwood Ave|*|Boston|*|02115|*|MA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_110.html|*||*|,MA342343725|*|38.864347|*|-77.239632|*|8505 Arlington Blvd|*|Fairfax|*|22031|*|VA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_132.html|*||*|,VA342343898|*|39.2903848|*|-76.6121893|*||*|Baltimore|*||*|MD|*|PROKIIDS |*|,crohns-disease|*||*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_137.html|*||*|,MD342343763|*|40.7738568|*|-73.9607231|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_133.html|*||*|,NY342344402|*|40.77225|*|-111.841536|*|50 N Medical Dr|*|Salt Lake City|*|84112|*|UT|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_118.html|*||*|,UT342344528|*|34.0641662|*|-118.442186|*|10833 Le Conte Ave|*|Los Angeles|*|90095|*|CA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_125.html|*||*|,CA342344039|*|47.662622|*|-122.2822311|*|4800 Sand Point Way NE|*|Seattle|*|98105|*|WA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_143.html|*||*|,WA342344079|*|34.073582|*|-118.380947|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_102.html|*||*|,CA342344444|*|39.297393|*|-76.59079|*|600 N Wolfe St|*|Baltimore|*|21205|*|MD|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_120.html|*||*|,MD342344491|*|41.7884212|*|-87.6040232|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_123.html|*||*|,IL342344476|*|36.1388928|*|-86.802261|*|2200 Children's Way|*|Nashville|*|37212|*|TN|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_122.html|*||*|,TN342344226|*|37.7749295|*|-122.4194155|*||*|San Francisco|*||*|CA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_108.html|*||*|,CA342344024|*|39.0830928|*|-94.5801123|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_142.html|*||*|,MO342344321|*|43.6569435|*|-79.388988|*|555 University Ave|*|Toronto|*||*|ON|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_113.html|*||*|342344336|*|40.7881467|*|-74.4652262|*|100 Madison Ave|*|Morristown|*|07960|*|NJ|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_114.html|*||*|,NJ342344384|*|33.9054263|*|-84.3569112|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_117.html|*||*|,GA342343933|*|36.1589529|*|-115.1690117|*|2040 W Charleston Blvd|*|Las Vegas|*|89102|*|NV|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_138.html|*||*|,NV342344556|*|30.243503|*|-81.547479|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_126.html|*||*|,FL342344597|*|45.3990082|*|-75.6530866|*||*||*||*||*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_129.html|*||*|342343988|*|38.6215188|*|-90.2383805|*|1465 S Grand Blvd|*|St Louis|*|63104|*|MO|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_140.html|*||*|,MO342344003|*|43.1232753|*|-77.627698|*|601 Elmwood Ave|*|Rochester|*|14642|*|NY|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_141.html|*||*|,NY342344142|*|41.7537933|*|-72.6826396|*|282 Washington St|*|Hartford|*|06106|*|CT|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_105.html|*||*|,CT342344368|*|39.777041|*|-86.179612|*|702 Barnhill Dr|*|Indianapolis|*|46201|*|IN|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_116.html|*||*|,IN342343964|*|41.5059114|*|-81.6071514|*|11100 Euclid Ave|*|Cleveland|*|44106|*|OH|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_139.html|*||*|,OH342344059|*|33.7980995|*|-84.3259367|*||*|Atlanta|*|30322|*|GA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_101.html|*||*|,GA342344095|*|39.954329|*|-75.191779|*|S 34th St|*|Philadelphia|*|19104|*|PA|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_103.html|*||*|,PA342344117|*|39.1031182|*|-84.5120196|*||*|Cincinnati|*||*|OH|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_104.html|*||*|,OH342344353|*|44.6388704|*|-63.5824473|*|5850 University Ave|*|Halifax|*||*|NS|*|PROKIIDS |*|,crohns-disease|*||*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_115.html|*||*|342344167|*|43.043614|*|-88.020787|*|8701 W Watertown Plank Rd|*|Milwaukee|*|53226|*|WI|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_106.html|*||*|,WI342344281|*|29.7079192|*|-95.4020717|*|6621 Fannin St|*|Houston|*|77030|*|TX|*|PROKIIDS |*|,crohns-disease,ulcerative-colitis|*|,pediatric-under-18|*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_111.html|*||*|,TX342344418|*|41.8119019|*|-71.4089546|*|593 Eddy St|*|Providence|*|02903|*|RI|*|PROKIIDS |*|,crohns-disease|*||*||*||*|,pro-kiids-pediatric-ibd|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/pn_119.html|*||*|,RI356597010|*|40.7382965|*|-73.9777379|*|341 E 25th St|*|New York|*|10010|*|NY|*|Randomized double-blind placebo-controlled crossover study of Trichuris suis ova (TSO) in patients with established ulcerative colitis|*|,ulcerative-colitis|*|,adult-18|*|,female,male|*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/MUCUS.html|*||*|,NY342344705|*|44.0221363|*|-92.4666658|*|200 1st St SW|*|Rochester|*|55902|*|MN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_7.html|*||*|,NY342344693|*|42.3618645|*|-71.0654433|*|165 Cambridge St|*|Boston|*|02114|*|MA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_6.html|*||*|,MA342344763|*|41.6569617|*|-91.5478736|*|200 Hawkins Dr|*|Iowa City|*|52242|*|IA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_11.html|*||*|,IA342344819|*|35.901785|*|-79.0535174|*|130 Mason Farm Rd|*|Chapel Hill|*|27514|*|NC|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_15.html|*||*|,NC342344795|*|39.2914839|*|-76.6250795|*|620 W Lexington St|*|Baltimore|*|21201|*|MD|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_13.html|*||*|,MD342344734|*|40.7904135|*|-73.9538335|*|1 Gustave L. Levy Pl|*|New York|*|10029|*|NY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_9.html|*||*|,NY342344632|*|29.709906|*|-95.40283|*|6620 Main St|*|Houston|*|77030|*|TX|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_2.html|*||*|,TX342344714|*|30.263886|*|-81.4428306|*|4500 San Pablo Rd S|*|Jacksonville|*|32224|*|FL|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_8.html|*||*|,FL342344878|*|36.1399776|*|-86.8181055|*|3319 West End Ave|*|Nashville|*|37203|*|TN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_20.html|*||*|,TN342344644|*|42.3362182|*|-71.0729293|*|85 E Concord St|*|Boston|*|02118|*|MA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_3.html|*||*|,MA342344667|*|43.7097034|*|-72.2868263|*|11 Rope Ferry Rd|*|Hanover|*|03755|*|NH|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_4.html|*||*|,NH342344866|*|43.0766466|*|-89.4312429|*|600 Highland Ave|*|Madison|*|53792|*|WI|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_19.html|*||*|,WI342344845|*|40.4442094|*|-79.9565118|*|123 University Pl|*|Pittsburgh|*|15213|*|PA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_17.html|*||*|,PA342344749|*|37.786606|*|-122.449558|*|3333 California St|*|San Francisco|*|94118|*|CA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_10.html|*||*|,CA342344681|*|46.7937341|*|-92.0952013|*|503 E 3rd St|*|Duluth|*|55805|*|MN|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_5.html|*||*|,MN342344616|*|33.909086|*|-84.350774|*|5671 Peachtree Dunwoody Rd NE|*|Atlanta|*|30342|*|GA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_1.html|*||*|,GA342344834|*|39.952222|*|-75.192236|*|3451 Walnut St|*|Philadelphia|*|19104|*|PA|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_16.html|*||*|,PA342344808|*|30.3096691|*|-81.6875334|*|2450 Riverside Ave|*|Jacksonville|*|32204|*|FL|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_14.html|*||*|,MN342344780|*|38.0328237|*|-84.5067424|*||*|Lexington|*|40536|*|KY|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_12.html|*||*|,KY342344856|*|40.7704811|*|-111.8367368|*||*|Salt Lake City|*|84132|*|UT|*|Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|*|,ulcerative-colitis|*|,adult-18|*||*||*|,clinical-trials|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/muc_18.html|*||*|,UT368936408|*||*||*||*||*||*||*|Risk of non-adherence to medications in IBD|*|,crohns-disease,ulcerative-colitis|*|,adult-18|*|,female,male|*|,mild,moderate,severe|*|,national-study|*|http://www.ccfa.org/research/participate-in-research/find-studies-and-clinical-trials/non-adherence.html|*||*|